[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Sources::
Editorial Board::
Executive Members::
Articles Archive::
Instruction to Authors::
Peer-Review::
Contact Us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: ::
Back to the articles list Back to browse issues page
9
Mohanna Yusefi1 , Mohammadrafi Damirchi2 , Alireza Norouzi * 3
1- Internal Medicine, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
2- General Physician, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
3- Associate Professor of Gastroenterology and Hepatology, Golestan Research Center of Gastroenterology and Hepatology (GRCGH), Department of Internal Medicine, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran. , norouzi54@gmail.com
Abstract:   (181 Views)
This article has no abstract.
Keywords: Liver Cirrhosis [MeSH], COVID-19 [MeSH], Chronic Disease [MeSH]
Full-Text [PDF 335 kb]   (153 Downloads)    
Type of Study: Short Communication | Subject: Infectious Medicine
References
1. Gao YD, Ding M, Dong X, Zhang JJ, Kursat Azkur A, Azkur D, et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021 Feb;76(2):428-55. doi: 10.1111/all.14657. [DOI] [PubMed]
2. Moon AM, Singal AG, Tapper EB. Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. Clin Gastroenterol Hepatol. 2020 Nov;18(12):2650-66. doi: 10.1016/j.cgh.2019.07.060. [DOI] [PubMed]
3. Sarin SK, Choudhury A, Lau GK, Zheng MH, Ji D, Abd-Elsalam S, et al. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). Hepatol Int. 2020 Sep;14(5):690-700. doi: 10.1007/s12072-020-10072-8. [DOI] [PubMed]
4. Bonnel AR, Bunchorntavakul C, Reddy KR. Immune dysfunction and infections in patients with cirrhosis. Clin Gastroenterol Hepatol. 2011 Sep;9(9):727-38. doi: 10.1016/j.cgh.2011.02.031. [DOI] [PubMed]
5. Iavarone M, D'Ambrosio R, Soria A, Triolo M, Pugliese N, Del Poggio P, et al. High rates of 30-day mortality in patients with cirrhosis and COVID-19. J Hepatol. 2020 Nov;73(5):1063-71. doi: 10.1016/j.jhep.2020.06.001. [DOI] [PubMed]
6. Su HY, Hsu YC. Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives. World J Clin Cases. 2021 May;9(13):2951-68. doi: 10.12998/wjcc.v9.i13.2951. [DOI] [PubMed]
7. Shalimar, Elhence A, Vaishnav M, Kumar R, Pathak P, Soni KD, et al. Poor outcomes in patients with cirrhosis and Corona Virus Disease-19. Indian J Gastroenterol. 2020 Jun;39(3):285-91. doi: 10.1007/s12664-020-01074-3. [DOI] [PubMed]
8. Peng Y, Qi X, Guo X. Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies. Medicine (Baltimore). 2016 Feb;95(8):e2877. doi: 10.1097/MD.0000000000002877. [DOI] [PubMed]
9. Tsai PH, Lai WY, Lin YY, Luo YH, Lin YT, Chen HK, et al. Clinical manifestation and disease progression in COVID-19 infection. J Chin Med Assoc. 2021 Jan;84(1):3-8. doi: 10.1097/JCMA.0000000000000463. [DOI] [PubMed]
10. da Rosa Mesquita R, Francelino Silva Junior LC, Santos Santana FM, Farias de Oliveira T, Campos Alcântara R, Monteiro Arnozo G, et al. Clinical manifestations of COVID-19 in the general population: systematic review. Wien Klin Wochenschr. 2021 Apr;133(7-8):377-82. doi: 10.1007/s00508-020-01760-4. [DOI] [PubMed]
11. Qi X, Liu Y, Wang J, Fallowfield JA, Wang J, Li X, et al. Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study. Gut. 2021 Feb;70(2):433-36. doi: 10.1136/gutjnl-2020-321666. [DOI] [PubMed]
12. Kim D, Adeniji N, Latt N, Kumar S, Bloom PP, Aby ES, et al. Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study. Clin Gastroenterol Hepatol. 2021 Jul;19(7):1469-1479.e19. doi: 10.1016/j.cgh.2020.09.027. [DOI] [PubMed]
13. Marjot T, Moon AM, Cook JA, Abd-Elsalam S, Aloman C, Armstrong MJ, et al. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study. J Hepatol. 2021 Mar;74(3):567-77. doi: 10.1016/j.jhep.2020.09.024. [DOI] [PubMed]
14. Moon AM, Webb GJ, Aloman C, Armstrong MJ, Cargill T, Dhanasekaran R, et al. High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry. J Hepatol. 2020 Sep;73(3):705-708. doi: 10.1016/j.jhep.2020.05.013. [DOI] [PubMed]
Send email to the article author


XML   Persian Abstract   Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Back to the articles list Back to browse issues page
مجله دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 0.04 seconds with 35 queries by YEKTAWEB 4657